Skip to main content

Table 3 Intra-day and inter-day precision and accuracy for the determination of TIG in intravenous infusion solution using the proposed methods

From: In situ green analytical methods for the rapid and sensitive determination of a newly launched orphan anticancer drug; Tigecycline in infusion bags: comparative study

Method

Conc. (µg/mL)

Average % recovery ± SDa

% RSDb

% Erc

(a) Accuracy and intra-day precision

CZE method

20

99.85 ± 1.52

1.52

− 0.15

100

99.23 ± 1.79

1.80

− 0.77

300

99.47 ± 0.34

0.34

− 0.53

Spectrophotometric methods

Method I

40

101.37 ± 0.42

0.42

1.37

100

98.60 ± 0.37

0.37

− 1.39

200

101.84 ± 0.37

0.37

1.84

Method IIA

40

100.85 ± 1.44

1.43

0.85

80

101.06 ± 1.55

1.53

1.06

140

98.61 ± 0.33

0.33

− 1.39

Method IIB

40

101.44 ± 0.85

0.83

1.44

80

101.82 ± 0.76

0.75

1.82

140

100.18 ± 0.61

0.61

0.18

Method III

20

100.38 ± 1.55

1.54

0.38

80

100.67 ± 0.46

0.46

0.67

140

99.38 ± 0.05

0.05

− 0.62

(b) Accuracy and inter-day precision

CZE method

20

101.18 ± 0.99

0.98

1.18

100

99.03 ± 1.97

1.99

− 0.97

300

98.78 ± 0.99

1.01

− 1.22

Spectrophotometric methods

Method I

40

101.86 ± 0.42

0.41

1.86

100

98.35 ± 0.56

0.57

− 1.65

200

101.60 ± 0.28

0.27

1.60

Method IIA

40

98.01 ± 1.93

1.96

− 1.99

80

100.92 ± 1.96

1.94

0.92

140

98.65 ± 0.19

0.19

− 1.35

Method IIB

40

99.58 ± 0.90

0.91

− 0.42

80

98.75 ± 1.41

1.43

− 1.25

140

100.14 ± 0.18

0.18

0.14

Method III

20

98.63 ± 0.57

0.58

− 1.37

80

99.41 ± 1.41

1.42

− 0.59

140

98.49 ± 1.18

1.19

− 1.51

  1. aAverage percentage recovery ± standard deviation for three determinations
  2. b% Relative standard deviation
  3. c% Relative error